Healthcare & Medical Devices Global On demand · 24-48h

Global Fully Threaded Suture Anchor Market Strategic Research Report

Global Fully Threaded Suture Anchor Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Fully Threaded Suture Anchor Market
$6512025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: No Knot, With Knot

By Application: Hospital, Clinic

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Beijing Delta Medical Science&Technology Corporation Ltd., Zimmer Biomet, Hangzhou Rejoin Mastin Medical Device Co., LTD, Shanghai Ligetai Biological Technology Co., Ltd., Canwell Medical Co., Ltd, Beijing Wanjie Medical Device Corporation Limited, Beijing Ke Yi Medical Device Technology Co., Ltd., Naton Biotechnology (Beijing) Co., Ltd., Inion, ArthroCare Corporation, Double Medical Technology Inc., Star Sports Medicine Co., Ltd., Shandong Weigao Orthopaedic Device Co., ltd., Conmed, Wright Medical Group N.V., Arthrex, Inc., Inion Oy, Anika

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 139 pages
Market size 2025
$651
Million USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$928.3
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Fully Threaded Suture Anchor market size is predicted to grow from US$ 651 million in 2025 to US$ 923 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

All-suture anchors are orthopedic implants made entirely of high-strength suture material, without traditional metal or rigid polymer anchors. They typically use compressible ultra-high molecular weight polyethylene (UHMWPE) suture bundles as the "anchor," pre-loaded with 1-4 high-strength sutures. After being inserted into the bone hole through a specialized guide, the suture bundle expands within the bone to achieve fixation. They are used for minimally invasive repair of soft tissue-bone interfaces such as the rotator cuff, ankle ligaments, and acetabular labrum. The upstream of the industry chain includes medical-grade UHMWPE fibers, high-performance polyester sutures, precision braiding and heat treatment equipment, and ethylene oxide sterilization service providers. The midstream consists of orthopedic innovation companies with Class III medical device registration certificates, requiring expertise in suture mechanical structure design, bone anchoring performance verification, fatigue testing, and GMP production systems. The downstream primarily targets sports medicine specialties and orthopedic departments in tertiary hospitals, entering clinical use through high-value consumables distributors or national/provincial orthopedic centralized procurement. In 2024, the global production of all-suture anchors was approximately 996,460 units, with an average price of US$633 per unit. The gross profit margin of major manufacturers is between 48% and 65%, with a single production line capacity of 10,000 units per year.

The market for Fully Threaded Suture Anchors continues to expand due to the rising number of sports injuries, aging populations, and increasing use of minimally invasive procedures such as arthroscopy. Advances in biomaterials, including high-strength polymers and bio-composites, enhance anchor performance and biocompatibility. Hospitals and surgeons prefer fully threaded designs due to superior pull-out strength and improved surgical stability. Additionally, outpatient orthopedic surgery centers are becoming major demand drivers. Manufacturers focus on cost efficiency, automated production, and expanding product portfolios with absorbable and all-suture variants. Overall, market momentum is supported by clinical demand, technology upgrades, and broader adoption of arthroscopic repair techniques worldwide.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fully Threaded Suture Anchor market?

What factors are driving Fully Threaded Suture Anchor market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fully Threaded Suture Anchor market opportunities vary by end market size?

How does Fully Threaded Suture Anchor break out by Type, by Application?

This report presents a comprehensive overview of the global Fully Threaded Suture Anchor market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • No Knot
  • With Knot

Segment by Material

  • Biocomposite Full Suture Anchor
  • PEEK Full Suture Anchor
  • All-Suture Fiber Anchor

Segment by Clinical Use

  • Rotator Cuff Repair
  • Ligament & Tendon Reinforcement
  • Minimally Invasive Arthroscopic Surger

Segment by Application

  • Hospital
  • Clinic

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Fully Threaded Suture Anchor market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Clinic evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Fully Threaded Suture Anchor Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$651
2025
Forecast
$928.3
2032
CAGR
5.2%
2025–2032
Regions
5
global
Key companies
Beijing Delta Medical Science&Technology Corporation Ltd.Zimmer BiometHangzhou Rejoin Mastin Medical Device Co., LTDShanghai Ligetai Biological Technology Co., Ltd.Canwell Medical Co., LtdBeijing Wanjie Medical Device Corporation LimitedBeijing Ke Yi Medical Device Technology Co., Ltd.Naton Biotechnology (Beijing) Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
No KnotWith Knot
By Application
HospitalClinic

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 No Knot
  • 3.1.3 With Knot
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Clinic
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Beijing Delta Medical Science&Technology Corporation Ltd.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Zimmer Biomet
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Hangzhou Rejoin Mastin Medical Device Co.,LTD
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Shanghai Ligetai Biological Technology Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Canwell Medical Co.,Ltd
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Beijing Wanjie Medical Device Corporation Limited
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Beijing Ke Yi Medical Device Technology Co.,Ltd.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Naton Biotechnology (Beijing) Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Inion
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ArthroCare Corporation
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Double Medical Technology Inc.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Star Sports Medicine Co.,Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shandong Weigao Orthopaedic Device Co.,ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Conmed
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Wright Medical Group N.V.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Arthrex,Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Inion Oy
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Anika
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Fully Threaded Suture Anchor market?
The global Fully Threaded Suture Anchor market is estimated at US$ 651 million in 2025 (base year) and is projected to reach US$ 923 million by 2032.
What is the forecast CAGR for the Fully Threaded Suture Anchor market?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 651 million in 2025 to US$ 923 million in 2032, roughly 1.4 times its base-year value.
What is Fully Threaded Suture Anchor?
All-suture anchors are orthopedic implants made entirely of high-strength suture material, without traditional metal or rigid polymer anchors. They typically use compressible ultra-high molecular weight polyethylene (UHMWPE) suture bundles as the "anchor," pre-loaded with 1-4 high-strength sutures. After being inserted into the bone hole through a specialized guide, the suture bundle expands within the bone to achieve fixation.
What are the main segments of the Fully Threaded Suture Anchor market by type?
By type, the market is segmented into No Knot and With Knot.
Which applications drive demand in the Fully Threaded Suture Anchor market?
Key applications covered include Hospital and Clinic.
Who are the key players in the Fully Threaded Suture Anchor market?
Key players profiled include Beijing Delta Medical Science&Technology Corporation Ltd., Zimmer Biomet, Hangzhou Rejoin Mastin Medical Device Co.,LTD, Shanghai Ligetai Biological Technology Co., Canwell Medical Co., Beijing Wanjie Medical Device Corporation Limited, Beijing Ke Yi Medical Device Technology Co. and Naton Biotechnology (Beijing) Co., among 18 companies covered in total.
Which regions and countries are covered for Fully Threaded Suture Anchor?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Fully Threaded Suture Anchor market?
Overall, market momentum is supported by clinical demand, technology upgrades, and broader adoption of arthroscopic repair techniques worldwide.
Who should buy the Fully Threaded Suture Anchor market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Clinic, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Fully Threaded Suture Anchor market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.